reversed-phase HPLC is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-08-13. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid in a sealed vial |
| Solubility class | Soluble in water and polar organic solvents | Reconstituted solutions are generally clear |
| Typical storage temperature | -20 degrees Celsius or below, dry | Protect from light; avoid repeated freeze-thaw cycles |
| Common analytical methods | Reversed-phase HPLC-UV, LC-MS | Used for purity estimation and mass confirmation |
| Reported purity range | Area percentage above 95 percent | Reporting practice and acceptance limits differ by laboratory |
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Prostaglandin E synthase (EC 5.3.99.3, or PGE synthase) is an enzyme involved in eicosanoid and glutathione metabolism, a member of MAPEG family. It generates prostaglandin E (PGE) from prostaglandin H2. The synthase generating PGE2 is a membrane-associated protein.
While both the CDET and the SDFT are positional tendons, enabling muscles to move the skeleton, the SDFT also stores energy and is far more elastic than the CDET due to "specialization of the [interfascicular matrix] to enable repeated interfascicular sliding and recoil." Desmosine concentrations were reported to be far greater in new tendons than in tendons that had partially degraded, suggesting that not only is there fragmentation of tendon elastin with age, but also a smaller total composition of elastin within the SDFT, though this was not true in the case of the CDET examined. Research has also been performed to determine the cross-linking structure of elastin, in an effort to better understand the relationship between elastin and pertinent diseases, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and aortic aneurysms. A study was conducted to find this structure through synthesis of a cyclic peptide containing desmosine, to partially mimic elastin in the hopes of running mass spectrometry on the peptide to reveal the cross-linking structure. The elastin mimic was eventually synthesized successfully, and though work has not yet been done to clarify the cross-linking structure of elastin, preliminary mass spectrometry demonstrated the presence of the expected ion formed from the chemical reactions used.
=== Alternative solution === An improvement to the methanizer is the Polyarc reactor, which is a sequential reactor that oxidizes compounds before reducing them to methane. This method can be used to improve the response of the FID and allow for the detection of many more carbon-containing compounds. The complete conversion of compounds to methane and the now equivalent response in the detector also eliminates the need for calibrations and standards because response factors are all equivalent to those of methane. This allows for the rapid analysis of complex mixtures that contain molecules where standards are not available.
Reincarnation is a paramount tenet in the Druze faith. There is an eternal duality of the body and the soul and it is impossible for the soul to exist without the body. Therefore, reincarnations occur instantly at one's death. While in the Hindu and Buddhist belief system a soul can be transmitted to any living creature, in the Druze belief system this is not possible and a human soul will only transfer to a human body. Furthermore, souls cannot be divided into different or separate parts and the number of souls existing is finite. A male Druze can be reincarnated only as another male Druze and a female Druze only as another female Druze. A Druze cannot be reincarnated in the body of a non-Druze. The cycle of rebirth is continuous and the only way to escape is through a complete soul purification. When this occurs, the soul is united with the Cosmic Mind and achieves the ultimate goal. In the major Christian denominations, the concept of reincarnation is not present and it is nowhere explicitly referred to in the Bible. However, the impossibility of a second earthly death is stated by 1 Peter 3:18–20, where it affirms that the messiah, Jesus of Nazareth, died once forever for the sins of all the human kind. Matthew 14:1–2 mentions that king Herod Antipas took Jesus to be a risen John the Baptist, when introducing the story of John's execution at Herod's orders. Some Christian theologians interpret certain Biblical passages as referring to reincarnation.
Sources: en.wikipedia.org
Following receipt of the test results and after further flights by USAAF pilots, the results were so positive that North American began work on converting several aircraft developing into the P-51B/C (Mustang Mk III) model, which became the first long-range fighter to be able to compete with the Luftwaffe's fighters. The definitive version, the P-51D, was powered by the Packard V-1650-7, a license-built version of the two-speed, two-stage-supercharged Merlin 66, introduced the "bubble" canopy, and was armed with six .50 caliber (12.7 mm) AN/M2 Browning machine guns. From late 1943 into 1945, P-51Bs and P-51Cs (supplemented by P-51Ds from mid-1944) were used by the USAAF's Eighth Air Force to escort bombers in raids over Germany, while the RAF's Second Tactical Air Force and the USAAF's Ninth Air Force used the Merlin-powered Mustangs as fighter-bombers, roles in which the Mustang helped ensure Allied air superiority in 1944. The P-51 was also used by Allied air forces in the North African, Mediterranean, Italian, and Pacific theaters. During World War II, Mustang pilots claimed to have destroyed 4,950 enemy aircraft. At the start of the Korean War, the Mustang, by then redesignated F-51, was the main fighter of the United States until jet fighters, including North American's F-86 Sabre, took over this role; the Mustang then became a specialized fighter-bomber. Despite the advent of jet fighters, the Mustang remained in service with some air forces until the early 1980s. After the Korean War, Mustangs became popular civilian warbirds and air racing aircraft.
== Entrepreneurial Activities == In 2000 Gerngross co-founded Glycofi, Inc. and served as the company's Chief Scientific Officer until its acquisition by Merck & Co. in the spring of 2006. In the fall of 2006 Dr. Gerngross joined SV Life Sciences as a venture partner where he advises on investments in the bio-therapeutics area. SV Life Sciences manages five investment funds with an aggregate capital of about $1.6 billion. In 2007 Dr. Gerngross co-founded Adimab LLC. with Prof. Dane Wittrup at MIT and Errik Anderson to develop a novel platform for the discovery of human antibodies in yeast. Gerngross stepped down from heading Adimab in February 2023, and was replaced by lawyer Philip Chase. To date the company has raised five rounds of venture financing from Polaris Ventures, SV Life Sciences, Google Ventures, OrbiMed Advisors, and Borealis Ventures and employs about 70 people in Lebanon, New Hampshire. In 2020, Gerngross cofounded Adagio as a spinout of Adimab which was developing a treatment for COVID-19. In Feb. 2022, Tillman Gerngross resigned as head of the company amid concerns about the efficacy of the drug. The company changed its name to Invivyd and broadened its focus in September 2022. There is currently a pending case of fraud against Tillman related to Adagio in Massachusetts, filed January 2023. In January 2022, Gerngross introduced a new company, Amagma, which also focused on developing antibodies. Amagma was folded in 2023, and the status of its assets are unknown.
A U.S. company named VAZTEC has created a compliant rotary valve sealing system that solves the friction and sealing problems of previous designs. They have built ten prototype engines from a 5.3L V-8 to a handheld 28cc four stroke. VAZTEC has also built a successful Diesel engine that contained the high compression pressures of a compression ignition engine (20:1 compression ratio, 100 bar combustion pressure). They are working with various OE manufacturers to commercialize their design. Various patents cover the compliant seal, including U.S. Patent 9,903,239. A Computational Fluid Dynamics (CFD) model of the VAZTEC rotary valve can be viewed at this link.
Sources: en.wikipedia.org
== Education and early life == Robert Joseph Paton Williams was born on 25 February 1926 in Wallasey to Ernest Ivor Williams, a customs and excise officer at Liverpool, and Alice Williams (née Roberts), a milliner; he was the second of four children. Williams failed to gain a scholarship to Wallasey Grammar School, having missed six months’ schooling with diphtheria, but his parents paid for him to attend. He went on to gain a place and be awarded a Postmastership to read chemistry at Merton College, Oxford in 1944. For his final undergraduate research year he worked with analytical chemist Harry Irving. This enabled him to establish an order of the relative stabilities of metal–organic complexes along the latter half of the transition series manganese through zinc. From these findings he saw a parallel with the selective uptake of metal ions by organisms. Williams’s plan was to continue working with Irving for his DPhil, but he first visited the lab of Arne Tiselius at Uppsala University. He was impressed by what he saw there, and returned to Sweden after he gained his DPhil in 1950. During the longer stay he worked on protein purification and devised a method called gradient elution analysis.
=== Extramitochondrial === At high glucose levels, glycolysis takes place rapidly, thus increasing the amount of citrate produced from the citric acid cycle. This citrate is then exported to other organelles outside the mitochondria to be broken into acetyl-CoA and oxaloacetate by the enzyme ATP citrate lyase (ACL). This principal reaction is coupled with the hydrolysis of ATP. At low glucose levels CoA is acetylated using acetate by acetyl-CoA synthetase (ACS), also coupled with ATP hydrolysis. Ethanol also serves as a carbon source for acetylation of CoA utilizing the enzyme alcohol dehydrogenase. Degradation of branched-chain ketogenic amino acids such as valine, leucine, and isoleucine occurs. These amino acids are converted to α-ketoacids by transamination and eventually to isovaleryl-CoA through oxidative decarboxylation by an α-ketoacid dehydrogenase complex. Isovaleryl-CoA undergoes dehydrogenation, carboxylation and hydration to form another CoA-derivative intermediate before it is cleaved into acetyl-CoA and acetoacetate. Additionally, malonyl-CoA decarboxylase (MCD), present in the cytosol, contributes to the extramitochondrial acetyl-CoA pool by converting malonyl-CoA into acetyl-CoA.
Alongside promotions of general law enforcement and upgrades to courts, the package also provided funding for strengthening the PET's activities in the North Atlantic, and provided new maritime equipment to Greenlandic and Faroese police in response to the crisis. By 19 January 2026, a total of over kr. 88 billion (US$13.7 billion) had been committed to "strengthen defense and security in the Arctic", with kr. 29 billion allocated to acquiring F-35 fighter jets alone, and kr. 27.8 billion for anti-aircraft warfare, according to the Ministry of Defence, and at that point Denmark had sent 200 additional soldiers to Greenland. On the same day, more soldiers together with the Chief of the Royal Danish Army, General Peter Harling Boysen, started arriving in Greenland, and Denmark announced that a "substantial contribution" of its armed forces would be sent there. Also on 19 January, Defence Minister Troels Lund Poulsen and Greenlandic Minister of Foreign Affairs Vivian Motzfeldt met NATO secretary general Rutte and their Nordic Security ministers in Brussels about the situation in Greenland. General Boysen said he is ready to defend Greenland. According to Boysen, the soldiers landed in Kangerlussuaq in western Greenland. On 20 January 2026, Denmark deployed additional troops to Greenland, sending dozens of soldiers and senior military leadership to the Arctic territory to reinforce its presence and participate in ongoing multinational exercises, increasing the Danish Armed Forces' personnel stationed there amid heightened international tensions.
Role of skin in locomotion describes how the integumentary system is involved in locomotion. Typically the integumentary system can be thought of as skin, however the integumentary system also includes the segmented exoskeleton in arthropods and feathers of birds. The primary role of the integumentary system is to provide protection for the body. However, the structure of the skin has evolved to aid animals in their different modes of locomotion. Soft bodied animals such as starfish rely on the arrangement of the fibers in their tube feet for movement. Eels, snakes, and fish use their skin like an external tendon to generate the propulsive forces need for undulatory locomotion. Vertebrates that fly, glide, and parachute also have a characteristic fiber arrangements of their flight membranes that allows for the skin to maintain its structural integrity during the stress and strain experienced during flight.
Sources: en.wikipedia.org
The dry powder is more stable during transport and storage than a solution. It also allows a known amount of material to be reconstituted at a chosen concentration.
Most certificates state a percentage derived from chromatographic peak area, alongside a mass confirmation. The exact criteria and acceptance thresholds vary between laboratories.
Dry powder is kept frozen or refrigerated and protected from light and moisture. Solutions are handled cold and used promptly to limit degradation.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.